InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong · Delayed Price · Currency is HKD 52.55
-0.45 (-0.85%)
Sep 10, 2026, 11:15 AM HKT
HKG:3696 Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Revenue Revenue Growth | 135.09 | 56.24 | 85.83 | 51.18 | 30.15 |
Revenue Growth | 140.20% | -34.48% | 67.71% | 69.77% | - |
Gross Profit Gross Profit Growth | 118.79 | 45.85 | 77.58 | 38.57 | 19.11 |
Operating Income Operating Income Growth | -9.36 | -59.99 | -37.33 | -83.73 | -80.12 |
Net Income Net Income Growth | -297.56 | -352.32 | -17.1 | -211.64 | -221.83 |
Earnings Per Share EPS Growth | -0.91 | -4.48 | -0.24 | -3.13 | -3.31 |
EPS Growth | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
United States United States Growth | 105.63 | 31.57 | 79.38 | 45.91 | 9.37 |
Chinese Mainland Chinese Mainland Growth | 19.39 | 17.53 | 2.14 | 3.45 | 9.24 |
France France Growth | 4.11 | 1.54 | - | - | - |
Korea Korea Growth | 1.09 | 0.22 | 0.28 | 0.05 | 0 |
Hong Kong Hong Kong Growth | 1.58 | 1.05 | 0.03 | 0.02 | 10.01 |
Others Others Growth | 0.52 | 0.62 | 0.26 | 0.21 | 0.08 |
Japan Japan Growth | 0.54 | 0.62 | 0.7 | 0.44 | 0.21 |
Kingdom of Saudi Arabia Kingdom of Saudi Arabia Growth | 1.01 | 1.82 | 1.9 | - | - |
Denmark Denmark Growth | 0.42 | 0.36 | 0.6 | 0.27 | - |
United Arab Emirates United Arab Emirates Growth | 0.05 | 0.28 | - | 0.01 | - |
United Kingdom United Kingdom Growth | 0.07 | 0.48 | 0.15 | 0.05 | 0.06 |
Germany Germany Growth | - | 0.08 | 0.03 | 0.09 | 0.33 |
Switzerland Switzerland Growth | - | 0.05 | 0.24 | 0.66 | 0.77 |
Taiwan Taiwan Growth | - | 0.01 | 0.11 | 0.03 | 0.08 |
Total Total Growth | 135.09 | 56.24 | 85.83 | 51.18 | 30.15 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Investments Cash & Investments Growth | 584.82 | 447.27 | 125.94 | 177.18 | 207.88 |
Total Debt Total Debt Growth | 19.66 | 5.96 | 2.56 | 2.19 | 3.22 |
Net Cash (Debt) Net Cash Growth | 565.16 | 441.31 | 123.38 | 174.99 | 204.66 |
Net Cash Growth | 28.06% | 257.68% | -29.49% | -14.50% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.73 | 5.61 | 1.72 | 2.59 | 3.05 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 39.06 | -76.77 | -57.4 | -29.58 | -47.52 |
Capital Expenditures CapEx Growth | -2.87 | -2.86 | -0.84 | -2.56 | -10.98 |
Free Cash Flow Free Cash Flow Growth | 36.19 | -79.62 | -58.25 | -32.14 | -58.5 |
Free Cash Flow Growth | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Gross Margin | 87.94% | 81.52% | 90.38% | 75.36% | 63.39% |
Operating Margin | -6.93% | -106.66% | -43.49% | -163.60% | -265.75% |
Pretax Margin | -220.06% | -626.36% | -19.73% | -413.36% | -735.78% |
Profit Margin | -220.28% | -626.46% | -19.92% | -413.52% | -735.82% |
FCF Margin | 26.79% | -141.58% | -67.86% | -62.79% | -194.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
PS Ratio | 28.81 | 47.15 | - | - | - |